TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/24 21:45 | 3/11/24 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Shah Preetam | CA | O | CFO,CBO | S | -13 | 0.6698 | 0 | -19 | -8 | 227 | D | ||||||||||||||
3/13/23 21:20 | 3/13/23 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Shah Preetam | CA | O | CFO,CBO | S | -10 | 1.53 | 0 | -7 | -4 | 148 | D | ||||||||||||||
9/19/22 20:28 | 9/15/22 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Shah Preetam | CA | O | CFO,CBO | M.d | 0 | 0.00 | 0 | 50 | 50 | 151 | D | ||||||||||||||
9/19/22 20:28 | 9/19/22 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Shah Preetam | CA | O | CFO,CBO | S.d | -12 | 0.7694 | 0 | -16 | -9 | 151 | D | ||||||||||||||
11/15/21 18:38 | 11/12/21 | CDTX | Cidara Therapeutics, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Shah Preetam | CA | O | CFO,CBO | P | 31 | 1.54 | 0 | 20 | New | 20 | D | ||||||||||||||
12/27/19 07:01 | 12/24/19 | BCLI | Brainstorm Cell Therapeutics Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Shah Preetam | NY | O | EVP,CFO, | P | 46 | 3.96 | 0 | 12 | 46 | 37 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |